Accepted for/Published in: JMIR Public Health and Surveillance
Date Submitted: Nov 6, 2023
Open Peer Review Period: Nov 5, 2023 - Nov 19, 2023
Date Accepted: May 23, 2024
Date Submitted to PubMed: May 23, 2024
(closed for review but you can still tweet)
Dose-response relationship between physical activity and the morbidity and mortality of cardiovascular disease among individuals with diabetes: A meta-analysis of prospective cohort studies
ABSTRACT
Background:
The link between physical activity (PA) and cardiovascular disease (CVD) risk remains unclear.
Objective:
This study aimed to summarize the evidence from prospective studies on the association between PA and CVD morbidity and mortality.
Methods:
We systematically reviewed prospective cohort studies in PubMed, EMBASE, and Web of Science up to December 2022, with inclusion criteria specifying adult participants. To assess potential bias, we employed funnel plots and Egger's test. Our analysis utilized random-effects models for qualitative evaluation and applied linear and spline regression techniques to estimate dose-response associations.
Results:
The meta-analysis of 12 prospective cohort studies, involving a total of 109,820 participants, revealed that higher levels of PA were associated with a reduced risk of CVD. The RR of CVD for the highest compared with the lowest PA category was 0.62 (95% CI, 0.51-0.73). The linear regression model revealed 10 MET-h/week of incrementally higher PA was associated with a 19.0% (95% CI, 11.6%-25.7%) and a 6.9% (95% CI, 4.5%-9.3%) reductions in CVD morbidity and mortality. Additionally, the spline regression curves showed nonlinear relationships between PA levels and the risk of CVD, with a limited reduction in CVD risk and some further reduction in CVD mortality in PA levels above 20 MET-h per week.
Conclusions:
Increased PA correlated with decreased CVD morbidity and mortality in individuals with diabetes. The observed PA threshold aligns with general population recommendations. Gradual transition from inactivity to recommended PA levels could significantly alleviate CVD burden in diabetics.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.